Biomarker development for pancreatic ductal adenocarcinoma using integrated analysis of mRNA and miRNA expression
暂无分享,去创建一个
Seungyeoun Lee | Taesung Park | Yongkang Kim | Min-Seok Kwon | Sung-Gon Yi | Junghyun Namkung | Sangjo Han | Meejoo Kang | Sun Whe Kim | Jin-Young Jang | Taegyun Yun | Jin‐Young Jang | Yongkang Kim | Min-Seok Kwon | T. Park | Sangjo Han | J. Namkung | Seungyeoun Lee | Sung-Gon Yi | M. Kang | S. Kim | Taegyun Yun
[1] C. Croce,et al. Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.
[2] Xiangyu Kong,et al. Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications , 2014, Gastroenterology research and practice.
[3] D. Bartel,et al. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs , 2004, Nature Reviews Genetics.
[4] Anna Goldenberg,et al. Identifying Cancer Specific Functionally Relevant miRNAs from Gene Expression and miRNA-to-Gene Networks Using Regularized Regression , 2013, PloS one.
[5] Yajian Jiang,et al. Discovery of novel candidate oncogenes in pancreatic carcinoma using high-throughput microarrays. , 2013, Hepato-gastroenterology.
[6] Young Woo Park,et al. Role of TMPRSS4 during cancer progression. , 2008, Drug news & perspectives.
[7] M. S. Lakshmi,et al. Angiogenesis in cancer , 1997 .
[8] A. Sokolenko,et al. High prevalence of GPRC5A germline mutations in BRCA1‐mutant breast cancer patients , 2014, International journal of cancer.
[9] Xuewu Zhang,et al. Biomarker validation: movement towards personalized medicine , 2007, Expert review of molecular diagnostics.
[10] F. Slack,et al. The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.
[11] E. Diamandis,et al. Strategies for discovering novel pancreatic cancer biomarkers. , 2013, Journal of proteomics.
[12] Akhilesh Pandey,et al. Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). , 2012, Journal of proteome research.
[13] Krishna R. Kalari,et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. , 2009, Cancer cell.
[14] Anushya Muruganujan,et al. Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.
[15] Renee Rubio,et al. Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue , 2009, Breast Cancer Research and Treatment.
[16] Hong Wu,et al. Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer , 2012, Clinical Cancer Research.
[17] Liviu Badea,et al. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. , 2008, Hepato-gastroenterology.
[18] George A. Calin,et al. MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.
[19] W. V. van IJcken,et al. Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction , 2010, PloS one.
[20] V. Mazzaferro,et al. Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.
[21] Miki Ohira,et al. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. , 2005, Cancer research.
[22] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[23] Hsien-Da Huang,et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions , 2013, Nucleic Acids Res..
[24] Tomoki Yokochi,et al. LMO3 interacts with p53 and inhibits its transcriptional activity. , 2010, Biochemical and biophysical research communications.
[25] Min Pan,et al. A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers , 2012, Genome research.
[26] H. Hermeking. The miR-34 family in cancer and apoptosis , 2010, Cell Death and Differentiation.
[27] Thomas Tuschl,et al. MicroRNAs in human cancer. , 2013, Advances in experimental medicine and biology.
[28] Stefanie Dimmeler,et al. Targeting microRNA expression to regulate angiogenesis. , 2008, Trends in pharmacological sciences.
[29] H. Xiao,et al. Global gene expression and functional network analysis of gastric cancer identify extended pathway maps and GPRC5A as a potential biomarker. , 2012, Cancer letters.
[30] M Paulli,et al. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma , 2009, Leukemia.
[31] C. Pilarsky,et al. Laminin, gamma 2 (LAMC2): A Promising New Putative Pancreatic Cancer Biomarker Identified by Proteomic Analysis of Pancreatic Adenocarcinoma Tissues* , 2013, Molecular & Cellular Proteomics.
[32] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[33] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[34] Nitin S. Baliga,et al. miRvestigator: web application to identify miRNAs responsible for co-regulated gene expression patterns discovered through transcriptome profiling , 2011, Nucleic Acids Res..
[35] Michael Kertesz,et al. The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.